GC1008
GC1008 | |
---|---|
Term | GC1008 |
Short definition | GBS - A rare condition in which the body's immune system attacks nerves located outside of the brain and spinal cord. Symptoms of GBS include muscle weakness, muscle pain, numbness, and tingling, which often starts in the legs or back and can spread to the arms, upper body, and face. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
GC1008 - A substance being studied for the treatment of breast cancer that has spread to other parts of the body. It is also being studied in the treatment of other cancers and diseases. GC1008 binds to a protein called transforming growth factor-beta (TGF-beta) found on some cancer cells. GC1008 can help prevent cancer cells from growing and prevent the growth of new blood vessels that tumors need to grow. It's a type of monoclonal antibody and a type of anti-angiogenesis drug. Also known as anti-TGF-beta monoclonal antibody GC1008 and fresolimumab
External links
- Medical encyclopedia article on GC1008
- Wikipedia's article - GC1008
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski